HALO
Halozyme Therapeutics, Inc. · Healthcare
SVP and Chief Technical Officer Michael J. Labarre sold $494K of Halozyme Therapeutics, Inc.
Sold$494,260
$49.43Price
10,000Shares
−6%Stake
What HALO did after the filing
- The stock from Thu, Jun 20 close, $50.86
- +6.4%
- S&P 500, same days
- −2.3%
Measured over 30 trading days, to the Aug 2 close.
Traded Tue, Jun 18. Filed Thu, Jun 20, 12:17 PM ET, during the session. Returns use the Jun 20 close and the Aug 2 close. Not investment advice.